Free Trial
NYSE:MCK

McKesson (MCK) Stock Price, News & Analysis

McKesson logo
$775.43 -16.50 (-2.08%)
Closing price 03:59 PM Eastern
Extended Trading
$772.50 -2.93 (-0.38%)
As of 05:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About McKesson Stock (NYSE:MCK)

Advanced

Key Stats

Today's Range
$774.45
$793.97
50-Day Range
$658.78
$791.40
52-Week Range
$492.39
$793.97
Volume
688,718 shs
Average Volume
862,225 shs
Market Capitalization
$96.45 billion
P/E Ratio
30.92
Dividend Yield
0.42%
Price Target
$834.54
Consensus Rating
Moderate Buy

Company Overview

McKesson Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
95th Percentile Overall Score

MCK MarketRank™: 

McKesson scored higher than 95% of companies evaluated by MarketBeat, and ranked 34th out of 948 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    McKesson has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 13 buy ratings, 3 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for McKesson is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    McKesson has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about McKesson's stock forecast and price target.
  • Earnings Growth

    Earnings for McKesson are expected to grow by 11.81% in the coming year, from $32.77 to $36.64 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of McKesson is 30.97, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 233.20.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of McKesson is 30.97, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.06.

  • Price to Earnings Growth Ratio

    McKesson has a PEG Ratio of 1.41. PEG Ratios above 1 indicate that a company could be overvalued.

  • Read more about McKesson's valuation and earnings.
  • Percentage of Shares Shorted

    1.97% of the float of McKesson has been sold short.
  • Short Interest Ratio / Days to Cover

    McKesson has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in McKesson has recently increased by 32.43%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    McKesson has a dividend yield of 0.43%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    McKesson has been increasing its dividend for 17 years.

  • Dividend Coverage

    The dividend payout ratio of McKesson is 13.08%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, McKesson will have a dividend payout ratio of 8.95% next year. This indicates that McKesson will be able to sustain or increase its dividend.

  • Read more about McKesson's dividend.
  • Percentage of Shares Shorted

    1.97% of the float of McKesson has been sold short.
  • Short Interest Ratio / Days to Cover

    McKesson has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in McKesson has recently increased by 32.43%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    McKesson has a news sentiment score of 1.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 47 news articles for McKesson this week, compared to 45 articles on an average week.
  • Search Interest

    36 people have searched for MCK on MarketBeat in the last 30 days. This is an increase of 125% compared to the previous 30 days.
  • MarketBeat Follows

    13 people have added McKesson to their MarketBeat watchlist in the last 30 days. This is an increase of 86% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, McKesson insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $16,722,190.00 in company stock.

  • Percentage Held by Insiders

    Only 0.08% of the stock of McKesson is held by insiders.

  • Percentage Held by Institutions

    85.07% of the stock of McKesson is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about McKesson's insider trading history.
Receive MCK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for McKesson and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MCK Stock News Headlines

The Zacks Analyst Blog Highlights UBS, Newmont, McKesson and The Cato
The 7 Warning Signals Flashing Red Right Now
A free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. Right now, all seven are flashing red simultaneously for the first time since 2007. These aren't the signals you'll see on CNBC.tc pixel
Top Research Reports for UBS, Newmont & McKesson
McKesson Valuation in Focus After Record Five Year Share Price Surge
McKesson stock reaches all-time high at $776.22
See More Headlines

MCK Stock Analysis - Frequently Asked Questions

McKesson's stock was trading at $569.91 at the beginning of 2025. Since then, MCK shares have increased by 36.3% and is now trading at $777.0550.

McKesson Corporation (NYSE:MCK) announced its earnings results on Wednesday, August, 6th. The company reported $8.26 earnings per share for the quarter, missing analysts' consensus estimates of $8.33 by $0.07. The business's quarterly revenue was up 23.4% compared to the same quarter last year.
Read the conference call transcript
.

McKesson subsidiaries include these companies: Echo, LloydsDirect, Medical Specialties Distributors, Well.ca, RxCrossroads, CoverMyMeds, HealthQx, and more.

Top institutional investors of McKesson include Swedbank AB (0.50%), Voya Investment Management LLC (0.48%), Pacer Advisors Inc. (0.45%) and Assenagon Asset Management S.A. (0.21%). Insiders that own company stock include Britt J Vitalone, Nancy Avila, Lori A Schechter, Brian S Tyler, Leann B Smith, Thomas L Rodgers, Napoleon B Rutledge Jr, Tracy Faber, Susan R Salka and Maria Martinez.
View institutional ownership trends
.

Shares of MCK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that McKesson investors own include Comcast (CMCSA), Chevron (CVX), Bristol Myers Squibb (BMY), Charles Schwab (SCHW), Edwards Lifesciences (EW), Yum! Brands (YUM) and Toronto Dominion Bank (TD).

Company Calendar

Last Earnings
8/06/2025
Record date for 10/1 Dividend
9/02/2025
Ex-Dividend for 10/1 Dividend
9/02/2025
Dividend Payable
10/01/2025
Today
10/16/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Health Care Distributors
Current Symbol
NYSE:MCK
CIK
927653
Employees
45,000
Year Founded
1833

Price Target and Rating

High Price Target
$900.00
Low Price Target
$688.00
Potential Upside/Downside
+5.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.88
Research Coverage
17 Analysts

Profitability

EPS (Trailing Twelve Months)
$25.08
Trailing P/E Ratio
31.55
Forward P/E Ratio
24.15
P/E Growth
1.41
Net Income
$3.30 billion
Net Margins
0.84%
Pretax Margin
1.15%
Return on Equity
-196.66%
Return on Assets
5.66%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.88
Quick Ratio
0.49

Sales & Book Value

Annual Sales
$377.60 billion
Price / Sales
0.26
Cash Flow
$39.33 per share
Price / Cash Flow
20.12
Book Value
($13.52) per share
Price / Book
-58.54

Miscellaneous

Outstanding Shares
124,384,000
Free Float
124,284,000
Market Cap
$98.44 billion
Optionable
Optionable
Beta
0.52

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:MCK) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners